No price history available for this symbol yet.
Held by
0
portfolios on TandT
Bookmarked by
0
users
Avg position size
—
of holders' portfolios
13F filers
0
institutions
Sector
Medical - Instruments & Supplies
Established in 2011 and based in Miaoli, Taiwan, Vizionfocus Inc. operates as a manufacturer of various sophisticated products. The company primarily produces medical equipment, serving key markets across Taiwan, China, Japan, and the United States. Its manufacturing capabilities also encompass mechanical equipment, optical instruments, and precision instruments. Beyond its production activities, Vizionfocus engages in global trade and delivers consultancy services. A significant area of its business involves the full lifecycle of contact lenses, from initial research and development to design, production, and wholesale distribution.
www.vizionfocus.comNo one on the platform currently holds 4771.TW.
No tracked institution reports a position in 4771.TW as of their last filing.
No one on the platform has traded 4771.TW yet.
Consensus-seeded revenue, margins, and exit multiples. This is a scenario tool, not investment advice.
Consensus does not cover every selected forecast year. Later assumptions are extrapolated from available analyst estimates.
| Metric | Historical average | My assumptions | ||||
|---|---|---|---|---|---|---|
| 1 year | 5 years | 10 years | Low | Mid | High | |
| ROIC % | 17.3% | 20.9% | — | — | — | |
| Rev. Growth % | 16.2% | 32.5% | ||||
| Profit Margin % | 21.2% | 19.8% | ||||
| Free Cash Flow Margin % | -2.2% | 1.8% | ||||
| Exit P/E | — | — | — | |||
| Exit P/FCF | — | — | — | |||
| Desired Annual Return % | — | — | — | |||
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
At today's price, your expected annual return is — on the P/E track.
No recent Form 4 filings on EDGAR — either no insider transactions reported recently or this isn't a SEC-registered issuer.
| Year | Est. revenue | Growth | Est. EPS | EPS range | Fwd P/E | # Analysts |
|---|---|---|---|---|---|---|
| 2026 | $4.7B | +34.2% | $17.69 | $17.06–$18.39 | — | 3 |
| 2027 | $5.5B | +17.1% | $20.99 | $19.53–$22.35 | — | 3 |
| 2028 | $5.9B | +6.3% | $22.32 | $21.50–$23.73 | — | 1 |
Forward consensus · growth is YoY vs the prior fiscal-year estimate · Fwd P/E at the current price · source: Financial Modeling Prep
Beat consensus in 4 of the last 7 reported quarters
| Reported | Est. EPS | Actual | Surprise |
|---|---|---|---|
| 2026-08-10 | $4.33 | $4.74 | +9.5% |
| 2026-05-11 | $3.76 | $3.66 | -2.7% |
| 2026-03-09 | $3.52 | $3.53 | +0.3% |
| 2025-11-10 | $3.38 | $3.27 | -3.3% |
| 2025-05-05 | $2.94 | $3.27 | +11.2% |
| 2025-03-10 | $2.79 | $2.86 | +2.5% |
| 2024-11-13 | $3.21 | $2.46 | -23.4% |
| $111.00 |
| +0.00% |
| $7.7B |
| — |
| 4126.TWOPacific Hospital Supply Co., Ltd | $77.70 | +0.00% | $5.6B | — |
| 4162.TWOPharmaEngine, Inc. | $54.70 | -0.18% | $7.9B | — |
Source: Financial Modeling Prep · peers by sector/industry